Recent Study: Oncimmune (USA) LLC - Product Pipeline Analysis, 2013 Update
Oncimmune (USA) LLC (Oncimmune) is a medical device company. The company detects lung cancer in high-risk patients. It offers EarlyCDT, which is a blood test that aids in the risk assessment and detection. Oncimmune uses technology such as autoantibody assay, which is based on biological technology. The company's EarlyCDT detects risk of cancer by detecting body's immune response in the form of autointibodies to antigens produced by solid tumor cells. It carries many tests and researches, and also anticipated the...
View full press release